Angiotensin II Modulation of Insulin-like Growth Factor I Expression in the Cardiovascular System
- 31 August 1996
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 6 (6) , 187-193
- https://doi.org/10.1016/s1050-1738(96)00058-8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK45215, HL45317, HL47035)
This publication has 52 references indexed in Scilit:
- G-Protein and Tyrosine Kinase Receptor Cross-Talk in Rat Aortic Smooth Muscle Cells: Thrombin- and Angiotensin II-Induced Tyrosine Phosphorylation of Insulin Receptor Substrate-1 and Insulin-like Growth Factor 1 ReceptorBiochemical and Biophysical Research Communications, 1996
- The IGF-1-IGF-1 Receptor System Modulates Myocyte Proliferation but Not Myocyte Cellular Hypertrophy in VitroExperimental Cell Research, 1994
- Hypertension increases insulin-like growth factor binding protein-4 mRNA levels in rat aorta.Hypertension, 1994
- Increased expression of growth hormone receptor mRNA and insulin-like growth factor-I mRNA in volume-overloaded hearts.Hypertension, 1994
- Upregulation of IGF1, IGF1‐receptor, and late growth related genes in ventricular myocytes acutely after infarction in ratsJournal of Cellular Physiology, 1994
- Vascular smooth muscle cells synthesize two forms of insulin‐like growth factor binding proteins which are regulated differently by the insulin‐like growth factorsJournal of Cellular Physiology, 1993
- Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteriesLife Sciences, 1991
- Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.Hypertension, 1991
- REDUCTION IN LEFT VENTRICULAR MASS IN NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS GIVEN ENALAPRILClinical and Experimental Pharmacology and Physiology, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987